c.dahlberg
TL2 · Nantes
Contributes reviews on supplier material. Based in Nantes.
Joined 14 March 2025 · last posted 2d
89 posts, newest first. Showing up to 150.
-
The anatomy of a question that gets answered within an hour Replied, post #126 · Start Here › How to Ask · 26 Jul 2026 · 0 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #123 · Evidence › Journal club · 21 Jul 2026 · 0 likes The most useful thing anyone has posted about SURMOUNT-OSA in this category was a table of what had been measured and by whom. That is what I would want again.
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #3 · Analytics › COA interpretation · 3 Jul 2026 · 21 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #76 · Start Here › How to Ask · 27 Jun 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Spreadsheets: an appreciation — what changed since Replied, post #82 · Lounge › Off topic · 26 Jun 2026 · 0 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
An 18-month record including the parts that went badly Replied, post #51 · Outcomes › Progress reports · 26 Jun 2026 · 0 likes One more thing on 18-month record that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #36 · Access › International · 25 Jun 2026 · 5 likes Travelling with a prescribed medicine is a documentation question and the requirements are published by the destination rather than the origin.
-
Tracking intake honestly when appetite is absent Replied, post #72 · Nutrition & Training › Protein & intake · 24 Jun 2026 · 0 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. A weak preference rather than a position.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #11 · Practice › Side effects · 23 Jun 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #32 · Pharmacology › Pharmacokinetics · 23 Jun 2026 · 10 likes No notes. Posting so the count is not one.
-
Documenting a supplier's response to a discrepancy Replied, post #19 · Sourcing › Vendor reports · 20 Jun 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #5 · Practice › Side effects · 19 Jun 2026 · 4 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
-
Revisiting: The best-written scientific paper you have read Replied, post #37 · Lounge › Off topic · 17 Jun 2026 · 2 likes That is clearer than the version I had in my head. Thank you.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #56 · Clinical › Comorbidities · 16 Jun 2026 · 9 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
-
When your prescriber and the evidence disagree Replied, post #15 · Clinical › Prescriber conversations · 16 Jun 2026 · 16 likes I read post #14 twice before replying, because I had assumed the opposite. If someone has run prescriber properly I would rather read that than my own reconstruction of…
-
Choosing a concentration on purpose rather than by accident Replied, post #3 · Practice › Reconstitution · 13 Jun 2026 · 6 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #59 · Compounds › Semaglutide · 11 Jun 2026 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Reused chromatograms across lots: how to spot it Replied, post #48 · Analytics › COA interpretation · 10 Jun 2026 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Designing a personal experiment that could change your mind — one year on Replied, post #56 · Research Methods › N-of-1 designs · 5 Jun 2026 · 12 likes Where I part company with post #54, and it is a narrow parting. I would be cautious about generalising from the Designing a personal experiment example above. It is a…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #58 · Devices › Syringes & needles · 1 Jun 2026 · 3 likes I disagree with the framing of 0.3 ml versus 0.5 ml above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Request: a per-category review queue Replied, post #13 · Meta › Feature requests · 1 Jun 2026 · 13 likes Building on post #10 rather than restating it. The practical version of per-category review queue is three sentences long. The rigorous version is three pages and…
-
Blind submission and why it changes minds — the long version Replied, post #84 · Sourcing › Independent verification · 19 May 2026 · 0 likes Post #82 put the caveat in the right place and I want to underline it. A record with four results over sixteen months is a thin record rather than a bad one, and the…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #20 · Analytics › Impurities & related substances · 16 May 2026 · 25 likes Before the thread moves on from Endotoxin — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Reading a trial's population section before its results Replied, post #3 · Evidence › Trials · 6 May 2026 · 2 likes Trial duration determines what can be observed. A weight-change trajectory at 40 weeks and at 72 weeks are different observations and both get quoted as the result.
-
Journal club: is percentage weight change the right endpoint? Replied, post #118 · Evidence › Journal club · 30 Apr 2026 · 4 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #98 · Analytics › Mass spectrometry · 20 Apr 2026 · 1 like Thank you for taking the time. That was more work than a reply usually is.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #44 · Clinical › Bloodwork · 20 Apr 2026 · 32 likes Ask what decision the result would change before ordering it. A test whose result changes nothing is a test that generates worry rather than information. Worth reading…
-
Coming back to: Time to steady state after a dose increase Replied, post #25 · Pharmacology › Pharmacokinetics · 2 Apr 2026 · 0 likes I had written a reply contradicting post #21 and deleted it. Here is what survived. Individual variation: people vary in how quickly they absorb, distribute,…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #19 · Practice › Administration · 2 Apr 2026 · 29 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #83 · Practice › Dosing & titration · 30 Mar 2026 · 0 likes I read post #81 twice before replying, because I had assumed the opposite. Writing down the date, the dose and the site each week takes fifteen seconds and is the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #52 · Compounds › Repair & healing peptides · 13 Mar 2026 · 31 likes I had written a reply contradicting post #51 and deleted it. Here is what survived. The distinction between "no evidence it works" and "evidence it does not work": we…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #59 · Analytics › Mass spectrometry · 6 Mar 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #63 · Regional › UK & Ireland · 4 Mar 2026 · 19 likes The most useful thing anyone has posted about pharmacy supply in this category was a table of what had been measured and by whom. That is what I would want again.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #84 · Evidence › Study critique · 25 Feb 2026 · 11 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
What a good consultation looks like from the other side Replied, post #17 · Clinical › Prescriber conversations · 16 Feb 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #11 · Start Here › Welcome · 9 Feb 2026 · 8 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.…
-
A partial dose because the pen emptied mid-injection Replied, post #15 · Practice › Administration · 7 Jan 2026 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer…
-
DXA precision and the least significant change for lean mass Replied, post #58 · Outcomes › Body composition · 10 Dec 2025 · 1 like This follows post #56 rather than contradicting it. Small correction to my own earlier position on DXA precision. I had the units the wrong way round, which changes the…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #86 · Practice › Reconstitution · 26 Nov 2025 · 13 likes Adding a data point of agreement rather than a data point.
-
Lurking for two months before posting: was that the right call? Replied, post #62 · Start Here › Welcome · 20 Nov 2025 · 5 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #9 · Compounds › Semaglutide · 20 Nov 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Long-time reader, first-time poster Replied, post #7 · Lounge › Introductions · 6 Nov 2025 · 1 like For anyone finding this later: the short answer on long-time reader is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #84 · Sourcing › Vendor reports · 2 Nov 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Sleep tracking data and its considerable limitations Replied, post #108 · Wellbeing › Sleep · 28 Oct 2025 · 20 likes Post #104 put the caveat in the right place and I want to underline it. The published data on sleep outcomes in this class is thinner than the volume of discussion,…
-
Second pass at: Programming during a large energy deficit Replied, post #56 · Nutrition & Training › Resistance training · 27 Oct 2025 · 1 like Taking post #55 at face value and following it one step further. On Programming during a large energy the community has more anecdote than the confidence in this thread…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #4 · Sourcing › Regulatory · 26 Oct 2025 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Mood changes: monitoring, and when to involve a professional — what changed since Replied, post #2 · Wellbeing › Mental health · 24 Oct 2025 · 13 likes Where medication for mental health is already in place, the interaction question belongs with a pharmacist and the mood question belongs with the prescriber. If anyone…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #10 · Start Here › Welcome · 12 Oct 2025 · 32 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Compounds this community declines to help with, and why Replied, post #84 · Compounds › Other compounds · 8 Oct 2025 · 0 likes Post #82 is right about the mechanism and I think understates the practical bit. Research use only, not approved for human use, and in this subcategory the compounds…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 9 likes Post #70 is the version of this I will quote in future. One addition. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #84 · Practice › Administration · 29 Sep 2025 · 32 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Reading a supplier's product description as a marketing document Replied, post #71 · Compounds › Other compounds · 16 Sep 2025 · 7 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Substitution between formats during a shortage Replied, post #55 · Access › Shortages · 12 Sep 2025 · 0 likes Worth separating two things that post #51 runs together. A note on scope: what I am saying about substitution between formats applies to the case in the first post and…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 12 Sep 2025 · 4 likes Very low total intake produces multiple simultaneous deficiencies rather than one, which is why single-nutrient reasoning goes wrong here.
-
Are there stupid questions here? A staff answer, at length Replied, post #107 · Start Here › Welcome · 24 Aug 2025 · 8 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #39 · Practice › Side effects · 18 Aug 2025 · 0 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
-
Pooling trials with different estimands — what changed since Replied, post #13 · Evidence › Meta-analyses · 14 Aug 2025 · 0 likes Adding the measurement that post #12 says would settle it. My experience of Pooling trials with different estimands contradicts the reply above. I am posting it as a…
-
Persistent vomiting and the threshold for seeking help Replied, post #14 · Safety › Adverse events · 4 Aug 2025 · 3 likes Fair, and the limits you put on it are the part I will remember.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #37 · Analytics › Home & field testing · 12 Jul 2025 · 15 likes If someone has run quantitation properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #2 · Compounds › Other compounds · 1 Jul 2025 · 2 likes The opening post describes the usual case. This is about the unusual one. Before the thread moves on from AOD-9604 — what is the sample size behind the claim? I am not…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 25 Jun 2025 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #26 · Practice › Dosing & titration · 17 Jun 2025 · 16 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #51 · Compounds › Cagrilintide & amylin analogues · 9 Jun 2025 · 5 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #26 · Devices › Syringes & needles · 8 Jun 2025 · 24 likes This follows post #23 rather than contradicting it. The quoted dead-volume figures for common configurations vary between manufacturers and the ordering is stable:…
-
Revisiting: German, French and Dutch differences, compared Replied, post #30 · Regional › European Union · 7 Jun 2025 · 14 likes I had written a reply contradicting post #28 and deleted it. Here is what survived. A device-and-compound combination has one authorisation and two supply chains, and…
-
Half-life, steady state, and accumulation worked through Replied, post #59 · Pharmacology › Pharmacokinetics · 3 Jun 2025 · 25 likes Post #58 answers the question as asked. The question underneath it is different. Careful with the language on half-life. "Not detected" and "not present" are different…
-
Washout: how long is long enough, and for what purpose Replied, post #15 · Pharmacology › Pharmacokinetics · 4 Apr 2025 · 0 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. Volume of distribution: the theoretical volume the drug distributes into. For…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #102 · Compounds › Cagrilintide & amylin analogues · 3 Apr 2025 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 3 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 12 likes I had written a reply contradicting post #86 and deleted it. Here is what survived. Agreed on amylin analogue mechanism, with one qualification that I think matters.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #22 · Wellbeing › Mental health · 23 Mar 2025 · 2 likes Answering the question post #18 raises rather than the one it answers. Whatever the answer on history of disordered eating turns out to be, the method for getting there…
-
How compounding permissions changed when supply normalised Replied, post #30 · Sourcing › Regulatory · 14 Mar 2025 · 8 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. It is one reading of the data and not…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #37 · Evidence › Journal club · 20 Feb 2025 · 30 likes My understanding of STEP 4 is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
What a seizure notice actually says Replied, post #35 · Sourcing › Logistics · 20 Feb 2025 · 20 likes Two claims get bundled together under seizure notice and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Preservatives: function, testing, and limits Replied, post #11 · Pharmacology › Formulation chemistry · 16 Feb 2025 · 0 likes Building on post #8 rather than restating it. I would put moderate confidence on the mainstream reading of preservatives and no more. That is not scepticism for its own…
-
Consistent declarations and why they matter more than clever ones Replied, post #39 · Sourcing › Logistics · 16 Feb 2025 · 0 likes Small correction to my own earlier position on consistent declarations. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Canadian access and provincial variation Replied, post #51 · Regional › North America · 3 Feb 2025 · 0 likes Everything in post #49 holds. The case it does not cover is the one I have. Provincial formularies in Canada are published and are the correct source for coverage…
-
Scheduled maintenance and what will be unavailable Replied, post #8 · Meta › Announcements · 4 Jan 2025 · 27 likes The reason scheduled maintenance is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #35 · Evidence › Journal club · 29 Dec 2024 · 8 likes Distinguishing three things in the SURMOUNT-1 discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #42 · Clinical › Special populations · 10 Dec 2024 · 3 likes Everything in post #41 holds. The case it does not cover is the one I have. Being outside the studied population does not mean a treatment is unsafe. It means the usual…
-
Coming back to: When to suspect the method rather than the sample Replied, post #42 · Analytics › Method validation · 8 Dec 2024 · 0 likes Building on post #39 rather than restating it. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #89 · Compounds › Repair & healing peptides · 19 Nov 2024 · 19 likes This follows post #86 rather than contradicting it. Practical experience of reading a preclinical wound-healing model, offered as one case with the conditions stated,…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #18 · Nutrition & Training › Resistance training · 11 Nov 2024 · 28 likes This follows post #17 rather than contradicting it. Recovery capacity falls with energy availability, so a programme that worked at maintenance may be too much during a…
-
Turnaround times and what they mean for a decision — one year on Replied, post #12 · Sourcing › Independent verification · 6 Nov 2024 · 1 like Post #11 is the version of this I will quote in future. One addition. I read the earlier replies on Turnaround times twice before writing this, because I had assumed…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #131 · Clinical › Bloodwork · 21 Oct 2024 · 22 likes Answering the bring a laboratory question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
Requesting a page: what makes a good request — what changed since Replied, post #37 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #51 · Analytics › COA interpretation · 12 Aug 2024 · 1 like Post #48 answers the question as asked. The question underneath it is different. I have no financial interest in anything named in this thread and I want to say so…
-
About the Retatrutide category Replied, post #3 · Compounds › Retatrutide · 9 Aug 2024 · 4 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #15 · Practice › Dosing & titration · 19 Jun 2024 · 11 likes Four-week escalation interval has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.